SIMMONDSIA CHINENSIS SEED OIL
What is SIMMONDSIA CHINENSIS SEED OIL (CAS 90045-98-0) in cosmetics and what are its global regulatory limits?
SIMMONDSIA CHINENSIS SEED OIL (CAS No. 90045-98-0) is a verified cosmetic ingredient primarily functioning as Hair Conditioning, Skin Conditioning, Emollient in topical formulations. Regulated under KR MFDS (Unregulated) and EU 1223/2009 CosIng (Unregulated) statutory frameworks, it is typically formulated at 1–6% within an optimal stability window of pH 4–8.
7-Track Official Regulatory Label Names Matrix
Primary Statutory Gazette Only · Zero Machine Translation| Jurisdiction Track | Official Statutory Label Name | One-Click Copy |
|---|---|---|
| 1. Korea (MFDS Standard Name) | SIMMONDSIA CHINENSIS SEED OIL (KR MFDS Registered) | |
| 2. Korea Former Nomenclature History | — | — |
| 3. European Union (EU CosIng Glossary) | SIMMONDSIA CHINENSIS SEED OIL | |
| 4. United States (US PCPC / MoCRA INCI) | SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL | |
| 5. US FDA OTC Monograph Active Name | — (Cosmetic Inactive / Non-OTC) | — |
| 6. China (NMPA IECIC Standard Name) | Unlisted in CN NMPA IECIC (Do Not Machine-Translate) | — |
| 7. Japan (JCIA Standard / MHLW Quasi-Drug) | SIMMONDSIA CHINENSIS SEED OIL (Standard INCI Reference) |
Layer 1 — Statutory Regulatory Limits Across 6 Regions
| Region | Status | Max Limit | Conditions & Statutory Source |
|---|---|---|---|
| Korea (MFDS) | Unregulated | GMP | Listed in official cosmetic inventory |
| Europe (EU) | Unregulated | GMP | Listed in official cosmetic inventory |
| United States (FDA) | Unregulated | GMP | Listed in official cosmetic inventory |
| China (NMPA) | Unregulated | GMP | Listed in official cosmetic inventory |
| Japan (MHLW) | Unregulated | GMP | Listed in official cosmetic inventory |
| ASEAN (ACD) | Unregulated | GMP | Listed in official cosmetic inventory |
Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit
Layer 3 — Formulation Usage Guide (Quartiles n≥5) & Physicochemical Compatibility
| Formulation Group | Min – Q1 – Median – Q3 – Max (%) | Role & Mechanism | Source ID |
|---|---|---|---|
| Group D — Sunscreen (UV) / Color Cosmetics / Foundation | 1% · 1% · 4% · 5% · 6% | Sun care & color cosmetics dispersion / sensory modifier | Global Starter Formulation Library Statistical Distribution (n=5, EVONIK 3 · GRANT 2) |
Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery
Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.
pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior
Outside pH 4–8, risk of hydrolysis, viscosity loss, or ionic dissociation increases.
Thermally stable up to 50°C during standard emulsification.
Cellular & Molecular Target Mechanism Flow
Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)
Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.
Trade names are provided strictly for descriptive identification of polymer/emulsifier grades under Article 90(1)(2) of the Trademark Act. All trademarks belong to their respective owners.
Academic & Toxicological Synthesis
Tier 1 SynthesisSynthesized strictly from peer-reviewed PubMed abstracts and official toxicological dossiers linked to this ingredient.
Linked Peer-Reviewed Literature (NIH PubMed) (2)
A Translational Cell-Culture Study of Jojoba Oil: Potential Uses and Safety Considerations for Nasal Applications [PMID: 41757774 · 2026]
The effects of Simmondsia chinensis seed oil on human nasal epithelial cells were the focus of this investigation. Nasal epithelial samples were obtained from physiologically sound tissue, as is customary in septorhinoplasty. As soon as the nasal epithelial tissues were received in the laboratory, they were processed. To remove residual blood and potential microbiological contaminants, the specimens were washed multiple times with phosphate-buffered saline (PBS) containing a 2% (v/v) antibiotic-antimycotic solution. The tissue pieces were then concentrated by centrifugation. The effects of Simmondsia chinensis seed oil on cell viability were evaluated by quantifying cellular metabolic activity using the MTT colorimetric assay. Afterward, cells were exposed to Simmondsia chinensis seed oil at concentrations of 1, 5, 15, 25, 50, 75, and 100 µL per well for a continuous 24-hour incubation period. The inhibitory curve was well-defined in the quantitative dose-response model that used nonlinear regression. A logIC₅₀ value of 0.8681 was used to compute the estimated half-maximal inhibitory concentration (IC₅₀), which was found to be 7.3 µL. The high level of reliability and reproducibility in the association between oil exposure volume and the observed reduction in cell viability is supported by the strong model fit (R²=0.9055). Analysis of metabolic activity in cells exposed to Simmondsia chinensis seed oil showed a strong inhibitory effect that increased with increasing oil concentration. Cell viability was expressed relative to untreated cells, which were assigned a reference value of 100%. A steady decline in viability was observed across the entire dose range evaluated, indicating that the oil's cytotoxic effects were strongly concentration-dependent. A statistical comparison was conducted to confirm these findings. The results showed that cell viability was significantly reduced at all tested exposure levels of Simmondsia chinensis seed oil compared with the negative control group. In addition, there was a strong dose-dependent cytotoxic effect, as statistical significance increased steadily with increasing exposure volumes. Ultimately, the viability and proliferation of nasal epithelial cells are reduced in a dose-dependent manner when exposed directly to Simmondsia chinensis seed oil. Nasal polyposis, granulation tissue formation after surgery, mucosal hyperplasia, and skin complications following rhinoplasty are among the otolaryngologic disorders that may benefit from the topical antiproliferative effects of Simmondsia chinensis seed oil. More clinical and experimental studies are needed to determine its therapeutic potential and safety profile before it may be used in clinical practice.
Evaluation of the mechanism of gelation of an oleogel based on a triterpene extract from the outer bark of birch [PMID: 23923639 · 2013]
Oleogels are known for their high physical, chemical, and mechanical stability and good in vivo efficacy, which make them appropriate vehicles for dermal drug delivery and skin care for very dry skin. Modern formulation research focusses on well tolerated and sustainable formulation concepts. This paper deals with an innovative oleogel, which is based on a triterpene dry extract from the outer bark of birch (TE). In this formulation TE does not only act as an excipient but provides interesting pharmacological properties at the same time. The oleogel was formulated using solely Simmondsia Chinensis seed oil (jojoba oil) and TE. Fluorescence microscopy and confocal Raman microscopy showed that suspended TE particles arrange in a three-dimensional gel network. Infrared spectroscopy revealed that the formation of hydrogen bonds between TE particles is responsible for the self-assembly of TE in oil. Moreover, the influence of TE concentration and morphology of the TE particles on the viscoelasticity of the resulting oleogels was analyzed. Gel strength increased with TE concentration and was critical to the specific surface area of the TE particles.
Frequently Asked Questions (AEO Position 0)
- Q1. What are the official 7-track regulatory label names for SIMMONDSIA CHINENSIS SEED OIL?
- Standard label names are US PCPC INCI: 'SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL', EU CosIng: 'SIMMONDSIA CHINENSIS SEED OIL', KR MFDS: 'SIMMONDSIA CHINENSIS SEED OIL (KR MFDS Registered)', CN NMPA IECIC: 'Unlisted in CN IECIC', and JP JCIA: 'SIMMONDSIA CHINENSIS SEED OIL'.
- Q2. Is SIMMONDSIA CHINENSIS SEED OIL restricted or permitted in EU, US, KR, CN, and JP cosmetics?
- Regulatory status summary across 6 jurisdictions — KR: none, EU: none, US: none, CN: none, JP: none, ASEAN: none.
- Q3. What is the typical formulation concentration and optimal pH window for SIMMONDSIA CHINENSIS SEED OIL?
- In sun_color systems, SIMMONDSIA CHINENSIS SEED OIL is typically formulated between 1% and 6% (median 4%), with an optimal stability window of pH 4–8.
- Q4. What are the known formulation incompatibilities and synergy pairings for SIMMONDSIA CHINENSIS SEED OIL?
- Recommended synergy pairings include GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL. Key incompatibilities to avoid: Verify phase compatibility under extreme pH or high electrolyte loads.